Cargando…
Advances in CGRP Monoclonal Antibodies as Migraine Therapy: A Narrative Review
Migraine is a potentially disabling disorder, yet it remains underdiagnosed and undertreated. The release of the neuropeptide calcitonin gene-related peptide (CGRP) in the trigemino-cerebrovascular system plays a vital role in the evolution of migraine. It enhances peripheral sensitization by mediat...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997852/ https://www.ncbi.nlm.nih.gov/pubmed/36909005 http://dx.doi.org/10.4103/sjmms.sjmms_95_22 |